In 2023, the import volume of cortisone, hydrocortisone, prednisone, and prednisolone to Brazil stood at an actual value not specified in the provided data. However, the forecasted data for 2024 through 2028 shows a consistent annual increase in imports.
The year-on-year percentage growth is as follows:
- 2024-2025: 2.44%
- 2025-2026: 2.38%
- 2026-2027: 2.26%
- 2027-2028: 2.15%
The compound annual growth rate (CAGR) for this period stands at approximately 2.29%.
Future trends to watch include Brazil's domestic production capabilities, shifts in healthcare policies, and potential changes in global supply chain dynamics that could impact import levels.
